Scaling Up Anti-Retroviral Treatment to (Injecting) Drug Users in Asia

Although anti-retroviral treatment (ART) is not traditionally considered a central concern in the harm reduction agenda, from a global public health perspective, Asian Harm Reduction Network (AHRN) believes that ART remains a very important service within a comprehensive HIV/AIDS treatment and care model. As such, AHRN’s analysis and experience in national, regional or international initiatives which have operational goals determined and evaluated through the provision of anti-retroviral (ARV) medications to people living with HIV/AIDS (PLWHA), demonstrates that we should applaud such treatment services on the principle that all people, regardless of ethnicity, religion, gender or sexual orientation, should receive quality treatment and health care.